# Non-Invasive Determination of Fetal Chromosome Abnormalities

> **NCT00891852** · — · UNKNOWN · sponsor: **Lenetix Medical Screening Laboratory** · enrollment: 1000 (estimated)

## Conditions studied

- Down Syndrome (Trisomy 21)
- Edward's Syndrome (Trisomy 18)
- Patau Syndrome (Trisomy 13)
- Klinefelter Syndrome (47, XXY)
- and Other Chromosome
- Abnormalities.

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00891852
- **Lead sponsor:** Lenetix Medical Screening Laboratory
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-01
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2009-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00891852

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00891852, "Non-Invasive Determination of Fetal Chromosome Abnormalities". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00891852. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*